Recursion Pharmaceuticals $200 million follow-on offering
We advised the underwriters on the offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Medtronic splits off MiniMed
This transaction completes Medtronic’s separation of its diabetes unit
Immix Biopharma $125 million stock offering
We advised the book-running manager on the offering
InnovAge $92.5 million secondary offering
We advised the underwriters on the offering
Sysco $1 billion follow-on offering
We advised the underwriters on the offering
Centrus $500M stock and pre-funded warrants and $2B common warrants offering
We advised the underwriters on the offering
Kawasaki Heavy Industries ¥97 billion stock offering
We advised the joint lead managers and joint bookrunners on the offering
ARCHION ¥235 billion secondary offering
We advised ARCHION and the selling shareholders on the offering
Corvex $33 million private placement
We advised Corvex on the PIPE
Coherus Oncology $50 million at-the-market offering
We advised the sales agent on the offering